Your dose-response curves will be skewed, your results will be weak or nonexistent, and your conclusions will be built on a faulty foundation
This initial dose sets the foundation for the treatment and ensures that the body can tolerate Zepbound (tirzepatide) effectively
The STZ group exhibited characteristic features of diabetic encephalopathy, including severe neuronal degeneration, pyknotic nuclei, cytoplasmic vacuolization, and disorganisation of the pyramidal cell layers in the hippocampus and cerebral cortex [43]
Clinical Evidence on GLP-1 Agonists and Headache Relief The SURMOUNT and SUSTAIN trials, which evaluated tirzepatide for weight loss and diabetes, documented migraine frequency as a secondary outcome in some patient cohorts
Welch RM, Conney AH, Burns JJ
I check my math using the formula or the online calculator